These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4834525)

  • 21. Persistent hypophosphataemia and osteomalacia in dialysis patients not on oral phosphate-binders: Response to dihydrotachysterol therapy.
    Ahmed KY; Varghese Z; Wills MR; Meinhard E; Skinner RK; Baillod RA; Moorhead JF
    Lancet; 1976 Aug; 2(7983):439-42. PubMed ID: 73742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of renal osteodystrophy with dihydrotachysterol in non-dialyzed patients.
    Teredesai P; Winaver J; Martin LG; Cranley R; Conner TB; Hartsock RJ; Puschett JB
    Clin Nephrol; 1980 Jan; 13(1):31-9. PubMed ID: 7363513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Complications of chronic glomerulonephritis from prolonged hemodialysis treatments].
    Gritsman AIu; Vishnevskaia RK
    Arkh Patol; 1974; 36(3):67-71. PubMed ID: 4451492
    [No Abstract]   [Full Text] [Related]  

  • 24. Bone aluminum and histomorphometric features of renal osteodystrophy.
    Hodsman AB; Sherrard DJ; Alfrey AC; Ott S; Brickman AS; Miller NL; Maloney NA; Coburn JW
    J Clin Endocrinol Metab; 1982 Mar; 54(3):539-46. PubMed ID: 7056841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication.
    Charhon SA; Chavassieux PM; Chapuy MC; Boivin GY; Meunier PJ
    J Lab Clin Med; 1985 Aug; 106(2):123-31. PubMed ID: 2410522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population.
    Andress DL; Maloney NA; Endres DB; Sherrard DJ
    J Bone Miner Res; 1986 Oct; 1(5):391-8. PubMed ID: 3503554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcifediol in chronic renal insufficiency. Skeletal response.
    Teitelbaum SL; Bone JM; Stein PM; Gilden JJ; Bates M; Boisseau VC; Avioli LV
    JAMA; 1976 Jan; 235(2):164-7. PubMed ID: 946022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled trial of calcitriol in hemodialysis patients.
    Baker LR; Muir JW; Sharman VL; Abrams SM; Greenwood RN; Cattell WR; Goodwin FJ; Marsh FP; Adami S; Hately W
    Clin Nephrol; 1986 Oct; 26(4):185-91. PubMed ID: 3536232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of hemodialysis on plasma fluoride.
    Cantürk NZ; Undar L; Ozbilum B; Cantürk M; Yalin R
    Mater Med Pol; 1992; 24(2):89-90. PubMed ID: 1307776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone histomorphometrical analysis in patients on long-term dialysis treatment for more than ten years.
    Ubara Y
    Osaka City Med J; 1998 Dec; 44(2):133-53. PubMed ID: 10097595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of binephrectomy on osteodystrophy due to chronic hemodialysis].
    Fournier A; Tunchott S; Bedrossian J; Idatte JM; Bordier P
    J Urol Nephrol (Paris); 1972 Dec; 78(12):1001-3. PubMed ID: 4661184
    [No Abstract]   [Full Text] [Related]  

  • 32. [Fibrous monostotic dysplasia with costal focus].
    Tritto VA; Prisco L
    Rass Int Clin Ter; 1971 Jun; 51(11):681-90. PubMed ID: 5110795
    [No Abstract]   [Full Text] [Related]  

  • 33. [Problems in treating the "aggressive" form of fibrous dysplasia (author's transl)].
    Blauth W; Meves H
    Z Orthop Ihre Grenzgeb; 1974 Apr; 112(2):230-5. PubMed ID: 4276732
    [No Abstract]   [Full Text] [Related]  

  • 34. Arrest of hyperparathyroid bone disease by the use of dihydrotachysterol in patients undergoing chronic hemodialysis.
    Kaye M; Chatterjee G; Cohen GF; Borra S; Sagar S
    Trans Assoc Am Physicians; 1970; 83():245-53. PubMed ID: 5505392
    [No Abstract]   [Full Text] [Related]  

  • 35. Bone disease in hemodialysis patients with particular reference to the effect of fluoride.
    Cordy PE; Gagnon R; Taves DR; Kaye M
    Trans Am Soc Artif Intern Organs; 1974; 20A():197-202. PubMed ID: 4450338
    [No Abstract]   [Full Text] [Related]  

  • 36. [Activity assessment of fibrous bone dysplasia using scintigraphy and thermography].
    Umek H; Czitober H; Meixner M; Strassl R
    Nucl Med (Stuttg); 1971 Oct; 10(3):276-85. PubMed ID: 5118984
    [No Abstract]   [Full Text] [Related]  

  • 37. Dihydrotachysterol (DHT) and supplemental calcium therapy in dialysis patients.
    Kliger AS; Yap P; Jensen P; Finkelstein FO
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():184-90. PubMed ID: 1029884
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of dihydrotachysterol on bone tissue in rats with experimental kidney failure].
    Iagodovskiĭ VS; Ermolenko VM; Spirichev VB; Blazheevich NV; Migunova NA
    Biull Eksp Biol Med; 1980 Nov; 90(11):611-3. PubMed ID: 7448398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoride metabolism in uremia.
    Nielsen E; Solomon N; Goodwin NJ; Siddhivarn N; Galonsky R; Taves D; Friedman EA
    Trans Am Soc Artif Intern Organs; 1973; 19():450-5. PubMed ID: 4722761
    [No Abstract]   [Full Text] [Related]  

  • 40. [Fibrous osteodysplasia in forensic medicine traumatology].
    Mikhaĭlova LN; Osipenkova-Vichtomova TK
    Sud Med Ekspert; 1993; 36(1):12-7. PubMed ID: 8036627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.